Du Cheng
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Molecular Biology top 5%
- RNA Interference and Gene Delivery
- CRISPR and Genetic Engineering
Papers in
- Biomaterials 24
- Nanoparticle-Based Drug Delivery 23
-
- RNA Interference and Gene Delivery 24
- CRISPR and Genetic Engineering 3
- Advanced biosensing and bioanalysis techniques 2
- Co-authors
- Xintao Shuai (44 shared papers)Mingqiang Li (21 shared papers)Seyin Zou (3 shared papers)Jian Dai (4 shared papers)Hong Ping Xiao (12 shared papers)Jifeng Chen (9 shared papers)Jingguo Li (9 shared papers)Shudong Lin (5 shared papers)
- Journals
- Biomaterials (8 papers)Biomaterials Science (4 papers)Small (4 papers)Journal of Biomedical Nanotechnology (4 papers)RSC Advances (4 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Du Cheng
82 papers receiving 5.1k citations
Du Cheng's Hit Papers
Peers
Comparison fields: 5 of 71
- Biomaterials 1.3k
- Molecular Biology 1.3k
- Biomedical Engineering 720
- Molecular Medicine 87
- Drug Discovery 1
Countries citing papers authored by Du Cheng
This map shows the geographic impact of Du Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Du Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Du Cheng more than expected).
Fields of papers citing papers by Du Cheng
This network shows the impact of papers produced by Du Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Du Cheng. The network helps show where Du Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Du Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 391 | |
| 2 | 2005 | 371 | |
| 3 | 2018 | 250 | |
| 4 | 2011 | 232 | |
| 5 | 2012 | 218 | |
| 6 | 2010 | 210 | |
| 7 | 2014 | 198 | |
| 8 | 2020 | 195 | |
| 9 | 2011 | 171 | |
| 10 | 2021 | 162 | |
| 11 | 2014 | 159 | |
| 12 | 2013 | 158 | |
| 13 | 2020 | 156 | |
| 14 | 2014 | 149 | |
| 15 | 2010 | 115 | |
| 16 | 2015 | 105 | |
| 17 | 2013 | 87 | |
| 18 | 2015 | 82 | |
| 19 | 2004 | 81 | |
| 20 | 2019 | 79 |
About Du Cheng
Du Cheng is a scholar working on Biomaterials, Molecular Biology, Biomedical Engineering, Polymers and Plastics and Biotechnology, having authored 83 papers that have together received 5.2k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (24 papers), Nanoparticle-Based Drug Delivery (23 papers), Nanoplatforms for cancer theranostics (10 papers), CRISPR and Genetic Engineering (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Ultrasound and Hyperthermia Applications (1 paper), Immune cells in cancer (1 paper) and Bone Tissue Engineering Materials (1 paper). The work is most often cited by research in Biomaterials (1.3k citations), Molecular Biology (1.3k citations), Biomedical Engineering (720 citations), Molecular Medicine (87 citations) and Drug Discovery (1 citation). Du Cheng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xintao Shuai, Mingqiang Li, Seyin Zou, Jian Dai, Hong Ping Xiao, Jifeng Chen, Jingguo Li, Shudong Lin, Yong Wang and Tinghui Yin. Their work appears in journals such as Biomaterials, Biomaterials Science, Small, Journal of Biomedical Nanotechnology and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.